None
Quote | ResMed Inc. (NYSE:RMD)
Last: | $178.85 |
---|---|
Change Percent: | -0.87% |
Open: | $179.15 |
Close: | $178.85 |
High: | $179.43 |
Low: | $176.9225 |
Volume: | 1,211,327 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | ResMed Inc. (NYSE:RMD)
2024-04-17 18:51:53 ET For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side). Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical ...
2024-04-17 10:30:28 ET More on Inspire Medical Systems Inspire Medical Systems: A Potential Example Of Market Mispricing Inspire Medical Systems: Strong Q4 Results But Growth Might Be Slowing Inspire Medical: A Good Night Sleep Baird puts Inspire on top idea ...
Message Board Posts | ResMed Inc. (NYSE:RMD)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $RMD News Article - ResMed Announces Participation in KeyBanc's Capital Markets' Life S | whytestocks | investorshangout | 03/16/2021 7:55:58 PM |
News; $RMD ResMed ($RMD) Q1 2021 Earnings Call Transcript | whytestocks | investorshub | 10/30/2020 10:45:25 PM |
$RMD was just on Cramers MAd mONEy tonight | TheFinalCD | investorshub | 04/01/2020 10:22:32 PM |
whytestocks: $RMD must see | whytestocks | investorshangout | 03/26/2020 6:10:46 PM |
News: $RMD Why ResMed Stock Is Shooting Higher Today | whytestocks | investorshub | 10/25/2019 5:00:26 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-17 18:51:53 ET For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side). Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical ...
2024-04-10 08:00:07 ET Craig Wong-Pan from RBC Capital issued a price target of $187.00 for RMD on 2024-04-10 07:09:00. The adjusted price target was set to $187.00. At the time of the announcement, RMD was trading at $194.27. The overall price target consensus is at $21...
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER). "I think Uber is ...